Barkley PMHNP Mock Certification
Exam II - Version 2.0
Comprehensive 150-Question
Practice Examination a well
detailed one written
and graded A+ upgraded
Instructions
This examination consists of 150 multiple-choice questions designed to assess entry-level
clinical knowledge and skills for the Psychiatric-Mental Health Nurse Practitioner (PMHNP)
certification exam. Questions reflect current psychiatric nursing standards, evidence-based
practice, DSM-5-TR diagnostic criteria, and clinical decision-making. Select the single best
answer for each question. Each question includes a detailed rationale explaining the correct
answer.
Exam Domains Covered:
• Scientific Foundation (Neurobiology, Pathophysiology, Psychopharmacology)
• Psychiatric Assessment and Differential Diagnosis
• Psychotherapy and Therapeutic Interventions
• Ethics, Legal Issues, and Professional Practice
, • Lifespan Considerations and Special Populations
SECTION I: NEUROBIOLOGY AND PATHOPHYSIOLOGY (Questions 1–25)
1. A 32-year-old patient with schizophrenia demonstrates significant cognitive impairment
affecting working memory and executive function. Which brain region is most associated with
these cognitive symptoms?
A. Hippocampus
B. Prefrontal cortex
C. Amygdala
D. Cerebellum
Correct Answer: B
Rationale: The prefrontal cortex is responsible for executive functions including working
memory, attention, and cognitive control. Cognitive symptoms of schizophrenia are associated
with prefrontal cortical dysfunction. The hippocampus (A) is involved in memory consolidation.
The amygdala (C) is involved in emotional processing. The cerebellum (D) is involved in motor
coordination.
2. A patient with major depressive disorder has failed multiple antidepressant trials. Genetic
testing reveals a polymorphism in the serotonin transporter gene (5-HTTLPR). This genetic
variation is associated with:
A. Increased response to SSRIs
B. Decreased response to SSRIs and increased risk of depression
C. Increased risk of bipolar disorder
D. Decreased risk of anxiety disorders
Correct Answer: B
Rationale: The short allele of 5-HTTLPR is associated with decreased serotonin transporter
expression, increased risk of depression, and poorer response to SSRIs. Increased response (A) is
incorrect. Bipolar disorder risk (C) is not directly associated. Decreased anxiety risk (D) is
opposite.
3. A patient with PTSD shows hyperresponsivity to threat-related stimuli. Which brain
structure is most implicated in this hyperarousal response?
,A. Prefrontal cortex
B. Amygdala
C. Hippocampus
D. Thalamus
Correct Answer: B
Rationale: The amygdala is central to fear processing and threat detection. Hyperactivity of the
amygdala is observed in PTSD, contributing to hyperarousal. The prefrontal cortex (A) is involved
in top-down regulation. The hippocampus (C) is involved in memory. The thalamus (D) is a
sensory relay.
4. A patient with schizophrenia is treated with a medication that blocks dopamine D2
receptors in the mesolimbic pathway. This action is most effective for treating:
A. Negative symptoms
B. Cognitive symptoms
C. Positive symptoms (hallucinations, delusions)
D. Depressive symptoms
Correct Answer: C
Rationale: D2 receptor blockade in the mesolimbic pathway reduces positive symptoms
(hallucinations, delusions). Negative symptoms (A) and cognitive symptoms (B) are less
responsive to D2 blockade. Depressive symptoms (D) are not the primary target.
5. A patient with bipolar disorder is prescribed lithium. Long-term lithium use is associated
with which endocrine effect?
A. Hyperthyroidism
B. Hypothyroidism
C. Hyperparathyroidism
D. Diabetes insipidus
Correct Answer: B
Rationale: Lithium is associated with hypothyroidism due to inhibition of thyroid hormone
synthesis and release. Hyperthyroidism (A) is not typical. Hyperparathyroidism (C) is less
common. Diabetes insipidus (D) is a renal effect, not endocrine.
, 6. The pathophysiology of Alzheimer's disease involves the accumulation of which protein
aggregates?
A. Alpha-synuclein
B. Tau and beta-amyloid
C. TDP-43
D. Prion proteins
Correct Answer: B
Rationale: Alzheimer's disease is characterized by extracellular beta-amyloid plaques and
intracellular neurofibrillary tangles composed of hyperphosphorylated tau. Alpha-synuclein (A)
is associated with Parkinson's disease. TDP-43 (C) is associated with frontotemporal dementia.
Prion proteins (D) are associated with prion diseases.
7. A patient with generalized anxiety disorder is prescribed a benzodiazepine. Chronic use
leads to tolerance through which mechanism?
A. Upregulation of GABA-A receptors
B. Downregulation of GABA-A receptors
C. Increased serotonin synthesis
D. Decreased dopamine release
Correct Answer: B
Rationale: Chronic benzodiazepine use leads to downregulation of GABA-A receptors,
contributing to tolerance and withdrawal symptoms. Upregulation (A) would occur with
antagonists. Serotonin synthesis (C) and dopamine release (D) are not primary mechanisms.
8. A patient with ADHD has been treated with a stimulant medication. The therapeutic effect
is primarily mediated through:
A. Blockade of dopamine reuptake and increased dopamine availability
B. Blockade of serotonin reuptake
C. GABA-A receptor potentiation
D. NMDA receptor antagonism
Correct Answer: A
Exam II - Version 2.0
Comprehensive 150-Question
Practice Examination a well
detailed one written
and graded A+ upgraded
Instructions
This examination consists of 150 multiple-choice questions designed to assess entry-level
clinical knowledge and skills for the Psychiatric-Mental Health Nurse Practitioner (PMHNP)
certification exam. Questions reflect current psychiatric nursing standards, evidence-based
practice, DSM-5-TR diagnostic criteria, and clinical decision-making. Select the single best
answer for each question. Each question includes a detailed rationale explaining the correct
answer.
Exam Domains Covered:
• Scientific Foundation (Neurobiology, Pathophysiology, Psychopharmacology)
• Psychiatric Assessment and Differential Diagnosis
• Psychotherapy and Therapeutic Interventions
• Ethics, Legal Issues, and Professional Practice
, • Lifespan Considerations and Special Populations
SECTION I: NEUROBIOLOGY AND PATHOPHYSIOLOGY (Questions 1–25)
1. A 32-year-old patient with schizophrenia demonstrates significant cognitive impairment
affecting working memory and executive function. Which brain region is most associated with
these cognitive symptoms?
A. Hippocampus
B. Prefrontal cortex
C. Amygdala
D. Cerebellum
Correct Answer: B
Rationale: The prefrontal cortex is responsible for executive functions including working
memory, attention, and cognitive control. Cognitive symptoms of schizophrenia are associated
with prefrontal cortical dysfunction. The hippocampus (A) is involved in memory consolidation.
The amygdala (C) is involved in emotional processing. The cerebellum (D) is involved in motor
coordination.
2. A patient with major depressive disorder has failed multiple antidepressant trials. Genetic
testing reveals a polymorphism in the serotonin transporter gene (5-HTTLPR). This genetic
variation is associated with:
A. Increased response to SSRIs
B. Decreased response to SSRIs and increased risk of depression
C. Increased risk of bipolar disorder
D. Decreased risk of anxiety disorders
Correct Answer: B
Rationale: The short allele of 5-HTTLPR is associated with decreased serotonin transporter
expression, increased risk of depression, and poorer response to SSRIs. Increased response (A) is
incorrect. Bipolar disorder risk (C) is not directly associated. Decreased anxiety risk (D) is
opposite.
3. A patient with PTSD shows hyperresponsivity to threat-related stimuli. Which brain
structure is most implicated in this hyperarousal response?
,A. Prefrontal cortex
B. Amygdala
C. Hippocampus
D. Thalamus
Correct Answer: B
Rationale: The amygdala is central to fear processing and threat detection. Hyperactivity of the
amygdala is observed in PTSD, contributing to hyperarousal. The prefrontal cortex (A) is involved
in top-down regulation. The hippocampus (C) is involved in memory. The thalamus (D) is a
sensory relay.
4. A patient with schizophrenia is treated with a medication that blocks dopamine D2
receptors in the mesolimbic pathway. This action is most effective for treating:
A. Negative symptoms
B. Cognitive symptoms
C. Positive symptoms (hallucinations, delusions)
D. Depressive symptoms
Correct Answer: C
Rationale: D2 receptor blockade in the mesolimbic pathway reduces positive symptoms
(hallucinations, delusions). Negative symptoms (A) and cognitive symptoms (B) are less
responsive to D2 blockade. Depressive symptoms (D) are not the primary target.
5. A patient with bipolar disorder is prescribed lithium. Long-term lithium use is associated
with which endocrine effect?
A. Hyperthyroidism
B. Hypothyroidism
C. Hyperparathyroidism
D. Diabetes insipidus
Correct Answer: B
Rationale: Lithium is associated with hypothyroidism due to inhibition of thyroid hormone
synthesis and release. Hyperthyroidism (A) is not typical. Hyperparathyroidism (C) is less
common. Diabetes insipidus (D) is a renal effect, not endocrine.
, 6. The pathophysiology of Alzheimer's disease involves the accumulation of which protein
aggregates?
A. Alpha-synuclein
B. Tau and beta-amyloid
C. TDP-43
D. Prion proteins
Correct Answer: B
Rationale: Alzheimer's disease is characterized by extracellular beta-amyloid plaques and
intracellular neurofibrillary tangles composed of hyperphosphorylated tau. Alpha-synuclein (A)
is associated with Parkinson's disease. TDP-43 (C) is associated with frontotemporal dementia.
Prion proteins (D) are associated with prion diseases.
7. A patient with generalized anxiety disorder is prescribed a benzodiazepine. Chronic use
leads to tolerance through which mechanism?
A. Upregulation of GABA-A receptors
B. Downregulation of GABA-A receptors
C. Increased serotonin synthesis
D. Decreased dopamine release
Correct Answer: B
Rationale: Chronic benzodiazepine use leads to downregulation of GABA-A receptors,
contributing to tolerance and withdrawal symptoms. Upregulation (A) would occur with
antagonists. Serotonin synthesis (C) and dopamine release (D) are not primary mechanisms.
8. A patient with ADHD has been treated with a stimulant medication. The therapeutic effect
is primarily mediated through:
A. Blockade of dopamine reuptake and increased dopamine availability
B. Blockade of serotonin reuptake
C. GABA-A receptor potentiation
D. NMDA receptor antagonism
Correct Answer: A
